Mr. Reichling oversees TMC Health’s planning, finance and business development functions, managing all financial affairs, directing real estate strategy, overseeing revenue cycle operations and payer contracting, and leading treasury functions. He is accountable for both capital and operational budgeting and for structuring complex transactions that support the system’s long-term sustainability and expansion. As CFO, Mr. Reichling led the acquisition and integration of a major oncology and radiation oncology clinic network, expanding the system’s regional presence and reinforcing its role as a leading provider in Southern Arizona. He designed TMC Health’s comprehensive five-year financial plan, aligning capital investments with core service lines and community-driven innovation, and he has safeguarded financial stability through volatile economic periods while enabling growth in patient-centered care. Under his leadership, TMC Health expanded key service lines, including the cancer center, gastroenterology, urology and cardiology, solidifying its position as the preferred regional healthcare provider. He also spearheaded a direct-to-consumer model that gives patients new ways to manage their health and connect directly with TMC Health services. Before TMC Health, Mr. Reichling served as CFO of Accelerate Diagnostics and as general manager and the director of finance and operations at Spring Bioscience, a subsidiary of Roche Group.
